InvestorsHub Logo
Followers 521
Posts 67089
Boards Moderated 1
Alias Born 06/10/2009

Re: None

Monday, 07/24/2017 9:12:51 AM

Monday, July 24, 2017 9:12:51 AM

Post# of 196224
$ECPO Updated Progress on the Validation Process for its ITV-1 Patented HIV/AIDS Treatment

The Company updated the progress on the initial validation order of 10,000 vials and the related documentation required for the issuance of the permit for mass production and sale. The production has been scheduled to begin in mid-September. The validation order will be completed in batches of 3,300+/- and the necessary documentation to complete the registration process will be delivered to the Bulgarian Drug Agency (BDA) during the manufacturing process. Upon successful completion of the validation and review of the resulting documentation by the BDA the issuance of the permit will allow the treatment to be sold wherever the permit issued by the BDA is recognized, including the Ukraine and other Eastern European countries. The Company expects additional orders to be placed in similar quantities on a monthly basis after the issuance of the permit under the existing Ukraine distribution agreement. Other distribution agreements are currently being negotiated.

https://www.otcmarkets.com/stock/ECPO/news